RT Journal Article
SR Electronic
T1 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001279
DO 10.1136/jitc-2020-001279
VO 8
IS 2
A1 Song, Yan
A1 Li, Ning
A1 Li, Qun
A1 Liang, Xinjun
A1 Zhang, Shu
A1 Fan, Qingxia
A1 Yin, Xianli
A1 Zhuang, Zhixiang
A1 Liu, Yunpeng
A1 Zhang, Jingdong
A1 Kou, Xiaoge
A1 Zhong, Haijun
A1 Wang, Xiaofei
A1 Dou, Yiwei
A1 Huang, Jing
YR 2020
UL http://jitc.bmj.com/content/8/2/e001279.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.